Tom Brady has been named chief wellness officer at eMed, a digital health startup offering clinically supervised GLP-1 care.
GLP-1s deliver dramatic weight loss, but a new study reveals what happens when treatment stops and why weight often comes back fast.
Life Time’s 2026 survey shows strength training overtaking weight loss as the top health priority, while longevity shapes fitness goals.
Despite the rise of GLP-1s, most Americans still struggle to turn weight-loss intent into action, new Gallup data shows.
Weight loss is a top priority for Americans amid the rise of GLP-1s, but rising emotional strain suggests the system is starting to crack
The new Weight Watchers app combines GLP-1 prescriptions with personalized nutrition tools, coaching and strength training offerings.
Noom’s microdose GLP-1 program targets early metabolic risk and longevity, offering weight-loss drugs to adults with a BMI of 21 or higher.
A new Ro survey shows GLP-1 stigma falls when people know someone taking the medication, suggesting personal ties are driving acceptance.
Les Mills and ukactive are urging the healthcare and fitness sectors to promote strength training and adequate protein intake for people taking weight-loss drugs.
Popular drugs like Ozempic are now a part of official global health recommendations from the World Health Organization to treat obesity.
Sign Up to Our Newsletter
